HC Wainwright Predicts Tourmaline Bio Q2 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Investment analysts at HC Wainwright issued their Q2 2026 EPS estimates for shares of Tourmaline Bio in a research note issued on Monday, May 5th. HC Wainwright analyst Y. Chen forecasts that the company will earn ($0.94) per share for the quarter. HC Wainwright has a “Buy” […]
